卵巣がん診断検査:医療機器パイプライン分析2020

【英語タイトル】Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020

GlobalDataが出版した調査資料(GD21MC021)・商品コード:GD21MC021
・発行会社(調査会社):GlobalData
・発行日:2020年11月30日
・ページ数:229
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD12,000 ⇒換算¥1,776,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Ovarian Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Summary

GlobalData’s Medical Devices sector report, “Ovarian Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020″ provides comprehensive information about the Ovarian Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Ovarian Cancer Diagnostic Tests include assays of mostly antibodies released in response to a ovarian cancer and cancer-causing proteins.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Ovarian Cancer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Ovarian Cancer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Ovarian Cancer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

❖ レポートの目次 ❖

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2.1 Ovarian Cancer Diagnostic Tests Overview
3 Products under Development
3.1 Ovarian Cancer – Pipeline Products by Stage of Development
3.2 Ovarian Cancer – Pipeline Products by Territory
3.3 Ovarian Cancer – Pipeline Products by Regulatory Path
3.4 Ovarian Cancer – Pipeline Products by Estimated Approval Date
3.5 Ovarian Cancer – Ongoing Clinical Trials
4 Ovarian Cancer – Pipeline Products under Development by Companies
4.1 Ovarian Cancer Companies – Pipeline Products by Stage of Development
4.2 Ovarian Cancer – Pipeline Products by Stage of Development
5 Ovarian Cancer Companies and Product Overview
6 Ovarian Cancer- Recent Developments
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Ovarian Cancer - Pipeline Products by Stage of Development
Table 2: Ovarian Cancer - Pipeline Products by Territory
Table 3: Ovarian Cancer - Pipeline Products by Regulatory Path
Table 4: Ovarian Cancer - Pipeline Products by Estimated Approval Date
Table 5: Ovarian Cancer - Ongoing Clinical Trials
Table 6: Ovarian Cancer Companies - Pipeline Products by Stage of Development
Table 7: Ovarian Cancer - Pipeline Products by Stage of Development
Table 8: 2cureX AB Pipeline Products & Ongoing Clinical Trials Overview
Table 9: IndiTreat - OVA - Product Status
Table 10: IndiTreat - OVA - Product Description
Table 11: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Companion Diagnostic Test - Ovarian Cancer - Product Status
Table 13: Companion Diagnostic Test - Ovarian Cancer - Product Description
Table 14: AB ANALITICA srl Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Predictive Biomarker Kit - Ovarian Cancer - Product Status
Table 16: Predictive Biomarker Kit - Ovarian Cancer - Product Description
Table 17: Accudava Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: SEPEX - Product Status
Table 19: SEPEX - Product Description
Table 20: SETAX - Product Status
Table 21: SETAX - Product Description
Table 22: Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 23: ImmunoSEQ Dx - Ovarian Cancer - Product Status
Table 24: ImmunoSEQ Dx - Ovarian Cancer - Product Description
Table 25: Almac Diagnostic Services Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 26: ALM AADx Assay - Product Status
Table 27: ALM AADx Assay - Product Description
Table 28: Diagnostic Test - Ovarian Cancer - Product Status
Table 29: Diagnostic Test - Ovarian Cancer - Product Description
Table 30: DNA Damage Response Deficiency Assay - Ovarian Cancer - Product Status
Table 31: DNA Damage Response Deficiency Assay - Ovarian Cancer - Product Description
Table 32: Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Multiplex Ovarian Cancer Biomarker Assay - Product Status
Table 34: Multiplex Ovarian Cancer Biomarker Assay - Product Description
Table 35: Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Cchek - Ovarian Cancer Confirmatory Test - Product Status
Table 37: Cchek - Ovarian Cancer Confirmatory Test - Product Description
Table 38: Cchek - Ovarian Cancer Recurrence Test - Product Status
Table 39: Cchek - Ovarian Cancer Recurrence Test - Product Description
Table 40: Cchek - Ovarian Cancer Screening Test - Product Status
Table 41: Cchek - Ovarian Cancer Screening Test - Product Description
Table 42: Cchek - Ovarian Cancer Treatment Monitoring Test - Product Status
Table 43: Cchek - Ovarian Cancer Treatment Monitoring Test - Product Description
Table 44: Anixa Diagnostics Corporation - Ongoing Clinical Trials Overview
Table 45: Cchek - Ovarian Cancer Screening Test - The Coupling of MDSCs with a Computational Analytic Method to Detect Solid Tumors
Table 46: AroCell AB Pipeline Products & Ongoing Clinical Trials Overview
Table 47: TK 210 Assay - Ovarian Cancer - Product Status
Table 48: TK 210 Assay - Ovarian Cancer - Product Description
Table 49: Arrayit Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Finger Stick Test - Ovarian Cancer - Product Status
Table 51: Finger Stick Test - Ovarian Cancer - Product Description
Table 52: Aspira Labs Pipeline Products & Ongoing Clinical Trials Overview
Table 53: OVA1 Plus Test - Product Status

List of Figures
Figure 1: Ovarian Cancer - Pipeline Products by Stage of Development
Figure 2: Ovarian Cancer - Pipeline Products by Territory
Figure 3: Ovarian Cancer - Pipeline Products by Regulatory Path
Figure 4: Ovarian Cancer - Pipeline Products by Estimated Approval Date
Figure 5: Ovarian Cancer - Ongoing Clinical Trials

★調査レポート[卵巣がん診断検査:医療機器パイプライン分析2020] (コード:GD21MC021)販売に関する免責事項を必ずご確認ください。
★調査レポート[卵巣がん診断検査:医療機器パイプライン分析2020]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆